Newsroom

ATLANTA--(BUSINESS WIRE)--Corpay, Inc. (NYSE: CPAY), the Global Spend Management company, today announced it has completed the sale of its UK-based vehicles maintenance business to OEConnection (OEC), a Francisco Partners portfolio company. “This is our second Vehicle Payments divestiture this year, and another step in shifting our portfolio toward Corporate Payments,” said Ron Clarke, Chairman and CEO of Corpay. “We’re concentrating our capital and management attention on fewer, bigger busines...

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether the directors of Distribution Solutions Group, Inc. (NASDAQ: DSGR) approved a buyout of Distribution Solutions Group for inadequate consideration, breaching their fiduciary duties to Distribution Solutions Group’s shareholders, and whether Distribution Solutions Group’s shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what sharehol...

EVERETT, Wash.--(BUSINESS WIRE)--Fortive Corporation (“Fortive”) (NYSE: FTV) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.07 per share of its common stock, par value $0.01 per share, payable on December 28, 2026, to stockholders of record on November 27, 2026. Although Fortive expects to pay dividends on a quarterly basis, any subsequent declaration of dividends, including the amount, the record dates, and the payment dates for any such future divi...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences. Susie Lisa, Senior Vice President, Investor Relations, and Manisha Pai, Executive Director, Investor Relations, will participate in a fireside chat at the UBS Global Biopharma Conference on Monday, November 16, 2026, at 9:20 a.m. GMT/4:20 a.m. EST. Susie Lisa and Manisha Pai will also participate in a fireside chat at the Jefferies Global H...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will present at the Jefferies Global Healthcare Conference in London on Monday, November 16, 2026 at 9:30 am GMT and members of management will be available for 1x1 meetings.A webcast of the presentation can be accessed...

DALLAS--(BUSINESS WIRE)--Celanese Announces Polyamide and Polyester Price Increases in Asia...

DALLAS--(BUSINESS WIRE)--Generational Group sponsors the 12th Annual Generational Salute, honoring veterans and supporting organizations that serve the military community....

LOS ANGELES--(BUSINESS WIRE)--Neutron Holdings, Inc. ("Lime" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Neutron Holdings, Inc. (NASDAQ: LIME), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Neutron Holdings, Inc. on November 3, 2026. If you lost mon...

HAMILTON, Bermuda--(BUSINESS WIRE)--Fortitude Re today announced a $200,000 donation to Cumberland River Compact through Fortitude Re 4 Good, the company’s umbrella for charitable giving, volunteerism and community partnerships. The company presented the contribution during a volunteer tree-planting event at LEAD Cameron Middle School in Nashville’s Chestnut Hill neighborhood. Cumberland River Compact brings together education, community engagement and hands-on conservation to support healthier...

BARRANQUILLA, Colombia & MIAMI--(BUSINESS WIRE)--Naturmega is pleased to celebrate the launch of LysOmega®, introduced last week by SourceOne Global Partners at SupplySide Global 2026 in Las Vegas. This innovative formulation is the result of a multi-year collaboration in which Naturmega contributed to the development, manufacturing, and supply of a specialized molecular matrix featuring EPA and DHA bonded to phospholipids rich in lysophosphatidylcholine (LPC), through its proprietary Ruby-O® t...